COSMO AMAT Q1 Net Loss and CB Issuance Raise Dilution Concerns, but Secures Growth Capital for Cathode Investments

Q1 2026 revenue increased 7.8% YoY to KRW 122.7B, but operating profit fell 16.3% to KRW 0.9B.
Net loss of KRW 35.7B (vs net profit of KRW 19.2B in Q1 2025) due to surge in financial costs (FX losses, derivative valuation losses).
EPS: -KRW 110 (vs KRW 59 in prior year).
In January 2026, issued KRW 120B convertible bonds (conversion price: KRW 44,051); in March, raised KRW 35B via third-party allotment. Total capital raised: KRW 155B.
Full conversion of CB could add up to 2.72M shares (8.2% dilution relative to current outstanding shares), raising dilution concerns for existing shareholders.
Proceeds earmarked for cathode material facility investments (domestic and overseas), expected to execute from Q2 2026 to end-2027.
Debt ratio increased to 50.5% (from 45.1% at year-end 2025); net debt-to-equity ratio improved to 16.8% (from 19.7%) due to large cash balance.
Cash and cash equivalents surged to KRW 105.6B (triple from KRW 35.0B at year-end 2025), significantly enhancing liquidity.
Major shareholder COSMO CHEMICAL's stake diluted to 26.61% (from 27.19%) due to new shares.
No dividends; company maintains investment-first policy over shareholder returns for now.
[AI Summary]Short-term earnings deterioration (net loss) and equity dilution from CB/equity issuance are negative, but the secured substantial funding for cathode capacity expansion supports mid-to-long-term growth. Investors should monitor future profitability recovery and investment payoffs.